WHAT IS MDM2? (MDMTWOMICS) MDM2 IN SARCOMAS? (MDMTWOMAS) MDM2MICS? NO CONFLICT OF INTERESTS 5/07/2018 MDM2 IN SOFT TISSUE AND BONE SARCOMAS

Similar documents
Update On Lipomatous Tumors: Old Standbys and New Concepts

MDM2 amplified sarcomas

Musculoskeletal Sarcomas

Mayo Medical Laboratories

Fun with Fat. General Rules. Case

Essential Dermatopathology. Jinah Kim, MD, PhD Department of Pathology and Dermatology Stanford University Medical Center

Case Report Primary Small Bowel Liposarcoma (Atypical Lipomatous Tumour) with Myogenic Differentiation

Disclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction

Taku Naiki, 1 Shuzo Hamamoto, 1 Noriyasu Kawai, 1 Aya Naiki-Ito, 2 Yoshiyuki Kojima, 1 Takahiro Yasui, 1 Keiichi Tozawa, 1 and Kenjiro Kohri 1

Department of Pathology, Sarcoma Research Center, UT-MD Anderson Cancer Center, Houston, TX, USA

Disclosures. Giant Cell Rich Tumors of Bone. Outline. The osteoclast. Giant cell rich tumors 5/21/11

3/27/2017. Disclosure of Relevant Financial Relationships

Primary bone tumors > metastases from other sites Primary bone tumors widely range -from benign to malignant. Classified according to the normal cell

Modern Pathology (2015) 28, & 2015 USCAP, Inc. All rights reserved /15 $

Adipocytic Tumours in children

The Scandinavian Sarcoma Group annual report on extremity and trunk wall soft tissue and bone sarcomas

Liposarcoma*Genome*Project*

Myxo-inflammatory Fibroblastic sarcoma

Disclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction

أملس عضلي غرن = Leiomyosarcoma. Leiomyosarcoma 1 / 5

Grading of Bone Tumors

Evening Specialty Conference Bone and Soft Tissue Pathology. Diagnostic pitfalls in bone and soft tissue pathology

Newer soft tissue entities

Multidisciplinary management of retroperitoneal sarcomas

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Immunohistochemistry in Bone and Soft Tissue Tumors. Sahar Rassi Zankoul, MD

5/10. Pathology Soft tissue tumors. Farah Bhani. Mohammed Alorjani

Malignant bone tumors. Incidence Myeloma 45% Osteosarcoma 24% Chondrosarcoma 12% Lyphoma 8% Ewing s Sarcoma 7%

ESS: Pathologic Insights

The Relevance of Cytologic Atypia in Cutaneous Neural Tumors

Update on Sarcomas of the Head and Neck. Kevin Harrington

A. Nahal MD,* A. Ajlan MD, T. Alcindor MD, and R. Turcotte MD P A T H O L O G Y ABSTRACT 2. CASE DESCRIPTION KEY WORDS 1.

IN THE NAME OF GOD Dr. Kheirandish Oral and maxillofacial pathology

Klinisch belang van chromosomale translocatie detectie in sarcomen

Automated Bright-Field Dual-Color In Situ Hybridization for MDM2

Pathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON

Kentucky Cancer Registry Spring Training 2017

Introduction to Musculoskeletal Tumors. James C. Wittig, MD Orthopedic Oncologist Sarcoma Surgeon

La chemioterapia neoadiuvante nei sarcomi: novità e attuali indicazioni Lorenzo D Ambrosio, MD PhD Divisione di Oncologia Medica Istituto di Candiolo

57th Annual HSCP Spring Symposium 4/16/2016

Surgery for Dedifferentiated Liposarcoma, Presenting Two Radiologically and Pathologically Distinctive Patterns

Paratesticular dedifferentiated liposarcoma with leiomyosarcomatous differentiation: a case report with a review of literature

Part 1. Slides 1-38, Rita Alaggio Soft tissue tumors Trondheim 14. mars 2013

USCAP 2014 Common problems in bone and soft tissue pathology: Cartilage tumors

CASE REPORT PLEOMORPHIC LIPOSARCOMA OF PECTORALIS MAJOR MUSCLE IN ELDERLY MAN- CASE REPORT & REVIEW OF LITERATURE.

Case 26 Male 37. Right jawline 5mm nodule?keloid. The best diagnosis is:

A 25 year old female with a palpable mass in the right lower quadrant of her abdomen

I sarcomi dei tessuti molli

Malignant Bone Tumours. PathoBasic, Daniel Baumhoer

JMSCR Vol 3 Issue 11 Page November 2015

ACCME/Disclosures ALK FUSION-POSITIVE MESENCHYMAL TUMORS. Tumor types with ALK rearrangements. Anaplastic Lymphoma Kinase. Jason L.

Bone/Osteoid Producing Lesions

Surgical Pathology Evening Specialty Conference USCAP 2015

Prognostic Significance of Grading and Staging Systems using MIB-1 Score in Adult Patients with Soft Tissue Sarcoma of the Extremities and Trunk

The Value of MRI in Distinguishing Subtypes of Lipomatous Extremity Tumors Needs Reassessment in the Era of MDM2 and CDK4 Testing

Khin Thway, 1 Jayson Wang, 2 John Swansbury, 3 Toon Min, 3 and Cyril Fisher Introduction

Lung Tumor Cases: Common Problems and Helpful Hints

Update on Cutaneous Mesenchymal Tumors. Thomas Brenn

Takayuki Ohguri 1 Takatoshi Aoki 1 Masanori Hisaoka 2 Hideyuki Watanabe 1 Katsumi Nakamura 1 Hiroshi Hashimoto 2 Toshitaka Nakamura 3 Hajime Nakata 1

Enterprise Interest Nothing to declare

Selected Pseudomalignant Soft Tissue Tumors of the Skin and Subcutis

Ultrasound screening of soft tissue masses in the trunk and extremity - a BSG guide for ultrasonographers and primary care

GIANT RETROPERITONEAL LIPOSARCOMA: IMAGING AND LITERATURE Amit Kumar 1, Sanjay K. Suman 2, Bipin Kumar 3, Sumit Kumar 4

Molecular pathology in soft tissue tumors. Sylvia Höller Pathologie

Keywords solitary fibrous tumor, dedifferentiation, dedifferentiated solitary fibrous tumor, STAT6, GRIA2, cytokeratin, rhabdomyosarcomatous

Case Report Primary Diaphragmatic Dedifferentiated Liposarcoma in a Young Female Patient after Delivery

MARK D. MURPHEY MD, FACR. Physician-in-Chief, AIRP. Chief, Musculoskeletal Imaging

Leiomyosarcoma of the inferior vena cava: 1 case. B. Bancel, A. Rode, C. Ducerf. Hôpital CROIX ROUSSE LYON. Case report

Disclosures. Parathyroid Pathology. Objectives. The normal parathyroid 11/10/2012

Case Report Primary cardiac dedifferentiated liposarcoma with homologous and heterologous differentiation: a case report

Bone Tumors Clues and Cues

Dedifferentiated liposarcoma (DDLPS) was a name

Myositis Ossificans Mimicking Sarcoma, the Importance of Diagnostic Imaging Case Report

Contents Part I Introduction 1 General Description 2 Natural History: Importance of Size, Site, Histopathology

Hsuan-Ying Huang 1, Murray F Brennan 2, Samuel Singer 2 and Cristina R Antonescu 1

Osteosarcomas. Osteosarcoma. Epidemiology 4/12/2018. David R. Lucas, MD

Liposarcomas are classified into myxoid, pleomorphic,

Case Presentation. Gordon Callender M.D. Surgical Resident

J of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 3/ Issue 19/May 12, 2014 Page 5307

GIANT CELL-RICH OSTEOSARCOMA: A CASE REPORT

Soft tissue lipomas, lipoma variants and liposarcomas: MRI evaluation and review of literature

Desmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC

Index. Note: Page numbers of article titles are in boldface type.

BioMed Research Journal

Dr. dr. Primariadewi R, SpPA(K)

In contrast to carcinomas of the breast, which rank

LAC + USC.

An Overview of Genital Stromal Tumors

Bone Tumours - a synopsis. Dr Zena Slim SpR in Histopathology QAH 2009

Fluid-fluid levels in bone tumors: A pictorial review

* I have no disclosures or any

Disclosure of Relevant Financial Relationships

DISORDERS OF THE SALIVARY GLANDS Neoplasms Dr.M.Baskaran Selvapathy S IV

Case 8 Soft tissue swelling

Radio-Pathologic Workup of a Retroperitoneal Abdominal Mass

Atypical Palisaded Myofibroblastoma of Lymph Node: Report of a rare case.

Tumors of Adipose Tissue Tumors Epidemiology Clinical Features. Morphology. Mature Adipocytes Separated by delicate fibrous septa

Financial disclosures

J of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 3/ Issue 46/Sep 22, 2014 Page 11296

Pleomorphic Liposarcoma: A Clinicopathologic Analysis Of 19 Cases

Transcription:

IN SOFT TISSUE AND BONE SARCOMAS WHAT IS? (MDMTWOMICS) Raf Sciot, M.D., PhD. Department of Pathology, University Hospitals Katholieke Universiteit Leuven, LEUVEN, Belgium IN SARCOMAS? (MDMTWOMAS) MICS? NO CONFLICT OF INTERESTS Murine Double Minute clone 2: oncogene in double minutes of spontaneously transformed mouse fibroblasts 12q15 Controls/blocks p53 activity: p53: nucleus cytoplasm, ubiquitination inhibits p53 transactivation domain

MICS? amplification/overexpression for cancer cells is an elegant means to block p53 7% of human cancers show amplification Molecules that block the -p53 interaction can reestablish wild type p53 activity MAS? Atypical lipomatous tumor/well differentiated liposarcoma Dedifferentiated liposarcoma Intimal sacoma Low grade osteosarcoma (parosteal/intramedullary) ATYPICAL LIPOMATOUS TUMOR/WELL DIFFERENTIATED LIPOSARCOMA Synonyms 40-45% liposarcoma Middle-aged adults, extremities (deep) > retroperitoneum, paratesticulum, mediastinum Variation adipocyte size/hyperchromatic/atypical nuclei/lipoblasts(+/-) Lipoma- like/sclerosing/inflammatory Prognosis: extremities >>> retroperitoneum

ATYPICAL LIPOMATOUS TUMOR/WELL DIFFERENTIATED LIPOSARCOMA Giant markers/supernumerary ring chromosomes: 12q13-15 Amplification of, CDK4, HMGA2, GLI1 FISH to detect amplification is very useful Cave immunohistochemistry: focal to negative nuclear macrophages often false + /CDK4/p16 immuno: sensitivity * *Thway et al. Am J Surg Path 2012;36: 462-469. lipoma-like sclerosing inflammatory spindle cell

CD68 Probes /12q15-BIO CDK4/12q14.1-DIG Well differentiated fatty tumor FISH test for recommended Recurrent lesion Deep extremity lesion >10 cm, pt > 50 years Equivocal atypia Retroperitoneum/abdomen/pelvis None of the above criteria but worrisome clinical/radiological features FISH test for not recommended Superficial location Hands/feet FISH probes: -SO (red) + CEP12-SG (green) as a reference probe (covering centromeric region of chromosome 12) Clay et al. Am J Surg Path 2015;39:1433-1439.

DEDIFFERENTIATED LIPOSARCOMA Transition of WDL/ALT towards a nonlipogenic sarcoma in 1 e tumor or recurrence The well differentiated component may be lacking 90% de novo, +/- 10% of WDL/ALT dedifferentiate Retroperitoneum (80%) > extremities most frequent retroperitoneal sarcoma extremity undifferentiated pleomorphic sarcoma with amplification = dediff. Liposarc*. *Le Guellec et al. Am J Surg Path 2014;38:293-304. DEDIFFERENTIATED LIPOSARCOMA Giant markers/supernumerary ring chromosomes: 12q13-15 (, CDK4, HMGA2 ) immuno usually strongly + 6p23, 1p32 (JUN!) co-amplification Well differentiated liposarcoma/atypical lipoma 12q amplification (, CDK4, ): low high level *Barretina et al. Nat Genetics 2010;42:715-721. Dedifferentiated liposarcoma 12q amplification (, CDK4, ): high level + JUN, YEATS4* DEDIFFERENTIATED LIPOSARCOMA Usually looks like a high grade spindle/pleomorphic sarcoma but also: myxoid, low grade looking, heterologous differentiation (chondro-, osteo-, myogenic ) Recurrence 40% Metastasis: 15-30% Correlation between grade and outcome?* * * *Dantey K et al. Human Pathol 2017;66:86-92. Male, 66 yrs, retroperitoneal tumor (35 cm)

Ring Ring chromosome FISH /12q15-BIO CDK4/12q14.1-DIG dod 3 yrs after resection: recurrences and inoperability Male, 83 yrs, retroperitoneal tumor (26 cm)

dod 5 yrs after resection (inoperable recurrence) Female, 58 yrs, retroperitoneal tumor

awd, inoperable recurrence after 3 yrs, chemotherapy Male, 52 yrs, tumor lower pole kidney: punction biopsy

FISH probes: -SO (red) + CEP12-SG (green) as a reference probe (covering centromeric region of chromosome 12)

INTIMAL SARCOMA Very rare, adults with broad age range Wall of large blood vessels, proximal pulmonary arteries most frequent Most frequent primary cardiac sarcoma* Very poor prognosis (embolic dissemination) Histology very heterogeneous: spindly/anaplastic/ myxoid/sclerotic/osteoid any weird looking intraluminal sarcoma: think intimal sarcoma! *Neuville et al. Am J Surg Path 2014;38:461-469. Male, 51 yrs, tumor pulmonary artery* *Cuppens et J Thorcic Oncol 2014;9:897-899 INTIMAL SARCOMA Amplification of 12q12-15: /CDK4 Amplification/activation of PDGFRα/KIT (4q12) and EGFR (7p11)

Boy, 4 yrs, tumor left ventricle 5/07/2018

PAROSTEAL OSTEOSARCOMA 4-5% of osteosarcoma, most frequent surface osteosarcoma Peak incidence in 3rd decade, slight female predominance 70%: posterior surface of distal femur, tibia, humerus also rarely involved Case 3 244k Agilent CGHarray analysis PDGFRA/KIT/VEGFR-2 /CDK4 EGFR EGFR PAROSTEAL OSTEOSARCOMA Log2(ratio) Log2(ratio) Log2(ratio) Case 2 Case 1 PDGFRA /CDK4 CDKN2A/CDKN2B /CDK4 Looks often benign. Fascicles of non-atypical spindle cells admixed with parallel bone trabeculae, +/- osteoblastic rimming. 50%: cartilage islands and CDK4 expression/amplification by immuno/fish Complete resection: 5 yr survival 91%. No chemotherapy, unless dedifferentiated (15-20%), then prognosis as in conventional type. 1 3 5 7 9 11 13 15 17 19 21 X 20 22 2 4 6 8 10 12 14 16 18 Chromosomes Dewaele et al. Cancer Research 2010;70:7304-7314

male, 14 yrs, increasing problems with knee flexion ned 14 yrs after resection

resection, after 3 yrs recurrence? Female, 19 yrs, slowly increasing pain in shoulder since 6 months, and palpable mass resection, after 3 yrs recurrence?

= recurrence of parosteal osteosarcoma! Male, 24 yrs, car accident 4 yrs ago, knee pain since then, recently increasing pain and swelling above the knee, biopsy and resection

dedifferentiation 5/07/2018

FISH: -SO + CEP12-SG (Kreatech) LOW GRADE CENTRAL OSTEOSARCOMA Permeation of pre-exsiting bone or soft tissue extension may be only clue for malignancy and CDK4 expression/amplification by immuno/fish Upon resection 5 yr survival = 90% Chemotherapy only in cases with progression to high grade osteosarcoma (10-36%) LOW GRADE CENTRAL OSTEOSARCOMA 1-2% of osteosarcoma 50% in 2nd-3rd decade Long bones lower extremity, mainly distal femur and proximal tibia Fascicular moderately cellular fibroblastic proliferation with minimal/no atypia Curved bone trabeculae (fibrous dysplasia-like) or long longitudinal seams of bone (parosteal osteosarcoma-like) Female, 57 yrs, painless swelling of knee

ned 12 yrs after resection FISH: -SO + CEP12-SG (Kreatech) 100x 60x

CONCLUSIONS M eaningful, molecular mechanism D M 2 iagnostic, FISH>Immuno aybe drugable make the life of a pathologist easier